ALEXANDRIA, Va., May 26 -- United States Patent no. 12,636,378, issued on May 26, was assigned to SRI International (Menlo Park, Calif.).
"Targeted antigen delivery system and uses thereof" was invented by Kathlynn C. Brown (Menlo Park, Calif.), Michael J. McGuire (Menlo Park, Calif.) and Indu Venugopal (Menlo Park, Calif.).
According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed are antigen delivery systems comprising a nanoparticle, wherein the nanoparticle is surface-modified with a cancer-specific cell targeting peptide and comprises an immunogenic HLA class I restricted peptide, wherein the HLA class I restricted peptide is a vaccine-dependent, immunogenic HLA class I restricted peptide; methods of treat...